Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects

NCT01520831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Healthy

Interventions

DRUG: biphasic insulin aspart 30
DRUG: biphasic insulin aspart 50
DRUG: biphasic insulin aspart 70
DRUG: insulin aspart

Sponsor

Novo Nordisk A/S